DTYMK and neoplasm: The kinase property of DTYMK has been harnessed for phosphorylating 3′-azido-3′-deoxythymidine (AZT) into AZT-triphosphate (AZT-TP) and disrupting the tumor cell cycle (Sato et al., 2007; Sato et al., 2013).